Análisis de competitividad y ventaja Financiera en la Internacionalización de Pequeñas y Medianas Empresas del Sector farmacéutico del Ecuador.

Abstract

Internationalization of small and medium-sized enterprises (SMEs) in the Ecuadorian pharmaceutical sector is becoming increasingly important as it allows them to access new markets and increase sales and profitability. However, this process also comes with a number of challenges, such as competition from foreign companies, trade barriers, and financial requirements. In the case of the Ecuadorian pharmaceutical sector, SMEs face a number of additional challenges, such as the need to comply with strict sanitary regulations, lack of access to financing, and competition from transnational companies. Despite these challenges, SMEs in the Ecuadorian pharmaceutical sector has significant competitive potential, as they have a solid foundation of knowledge and experience in the development and production of medicines. To maintain their competitiveness at the international level, SMEs in the Ecuadorian pharmaceutical sector must continue to invest in innovation and management improvement. In particular, it is important for these companies to develop new products and services that meet the needs of international markets and improve their production and distribution processes. In addition to competitiveness, financial advantage is another key factor for the success of SME internationalization. Companies with a strong financial position are more likely to overcome the challenges of internationalization, such as initial investment, risk of loss, and need for liquidity. In the case of SMEs in the Ecuadorian pharmaceutical sector, financial advantage is a critical factor, as these companies typically have limited financial resources.